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Background: Stent fracture (SF) after drug-eluting stent (DES) implantation has been reported to be associated with target lesion 
revascularization. We have proposed stent axial recoil at lesions of DES implantation, especially at SF lesions and named it stent recoil (SR). We 
evaluated the midterm outcomes of SR with SF after various DES implantations.
methods and results: The study population consisted of 11617 lesions (5068 patients) that were treated exclusively with DES from 2003 to 
2012. Midterm follow-up angiography was scheduled at 8 months after procedure. SF was defined as the separation of stent segments or stent 
struts. SR was defined as axial recoil less than 80% in stent diameter. SF was observed in 494 lesions (446 patients) and SR with SF in 138 lesions 
(129 patients). As the figure shows, the incidence of SR with SF after biolimus-eluting stent implantation was significantly lower than those after 
sirolimus-eluting, paclitaxel-eluting, and Pt-Cr everolimus-eluting stent implantations (13.4%, 29.0%, 39.1%, and 54.5%, respectively). On the other 
hand, regardless of DES type, the rate of restenosis and target lesion revascularization (TLR) at SR with SF lesions were higher than those at non-SR 
with SF lesions.
conclusion: The incidence of SR in SF lesions could be related to DES type. SR appears to affect the midterm outcomes of SF lesions regardless of 
DES type. 
